PMGC Holdings Inc. (ELAB) stock
ELABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/3095% below fair value
$1.48−0.18 (-10.84%)
Close on Nov 17, 2026Market cap $1.32MP/E –Yield –
PMGC profit margin
Profit margin (net margin) is net income as a percentage of revenue.
PMGC's profit margin for the twelve months ending Sep 30, 2026 was -275.7%. For fiscal 2025 it was -1313.0%, against -251.2% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -1313.0% | −1061.8 |
| FY2023 | Dec 31, 2023 | -251.2% | −16.2 |
| FY2022 | Dec 31, 2022 | -234.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -95.1% | +812.2 |
| Q2 FY2026 | Jun 30, 2026 | -225.1% | +59.5 |
| Q1 FY2026 | Mar 31, 2026 | -728.3% | −495.1 |
| Q4 FY2025 | Dec 31, 2025 | -980.7% | −753.4 |
| Q3 FY2025 | Sep 30, 2025 | -907.3% | −741.5 |
| Q3 FY2024 | Sep 30, 2024 | -284.6% | −143.4 |
| Q2 FY2024 | Jun 30, 2024 | -233.3% | +171.1 |
| Q1 FY2024 | Mar 31, 2024 | -227.4% | +529.3 |
| Q4 FY2023 | Dec 31, 2023 | -165.8% | −50.3 |
| Q3 FY2023 | Sep 30, 2023 | -141.2% | – |
| Q2 FY2023 | Jun 30, 2023 | -404.3% | – |
| Q1 FY2023 | Mar 31, 2023 | -756.7% | – |
| Q3 FY2022 | Sep 30, 2022 | -115.5% | – |
See a number that looks wrong?